Qube Research & Technologies (QRT)
ACIU icon

Qube Research & Technologies (QRT)’s AC Immune ACIU Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ACIU Stock Details ACIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-48
Closed -$192 – 3221
2024
Q2 		$192 Hold
48
– – ﹤0.01% 3396
2024
Q1 		$142 Buy
+48
New +$172 ﹤0.01% 4161
2023
Q4 		– Sell
-186
Closed -$530 – 4299
2023
Q3 		$530 Buy
+186
New +$566 ﹤0.01% 3675
2020
Q4 		– Sell
-26,828
Closed -$131K – 1758
2020
Q3 		$131K Buy
+26,828
New +$193K ﹤0.01% 1464

Other funds holding ACIU

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Qube Research & Technologies (QRT)'s ACIU Position: Q3 2024 in Review

Qube Research & Technologies (QRT) sold out of AC Immune (ACIU) in Q3 2024, closing a stake of 48 shares — an estimated $192 sold.

Qube Research & Technologies (QRT) first reported a position in ACIU in Q3 2020 and held it in 4 quarters. The position peaked at $131K in Q3 2020. 43 funds tracked by Wall St. Rank hold ACIU as of Q3 2024.

  • Qube Research & Technologies (QRT) reported no remaining AC Immune position as of Q3 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 48 AC Immune shares in Q3 2024, an estimated $192.
  • Qube Research & Technologies (QRT) first reported a position in AC Immune in Q3 2020 and held it in 4 quarters.
  • Qube Research & Technologies (QRT)'s AC Immune position peaked at $131K in Q3 2020.
  • 43 funds tracked by Wall St. Rank held AC Immune as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.